Back

Safety of omitting defibrillation efficacy testing with subcutaneous defibrillators: a propensity matched case-control study

23 April 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: News from ICD therapy Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2021

About the speaker

Photo
Doctor Valter Bianchi

AO dei Colli - Monaldi Hospital, Naples (Italy)

7 More presentations in this session

Presentation thumbnail
Five year outcomes of the subcutaneous implantable cardioverter-defibrillator EFFORTLESS (evaluation of factors impacting clinical outcome and cost effectiveness of the S-ICD) registry
Professor P. Lambiase (London, GB)
Abstract Slides Video
Presentation thumbnail
Accelerometry-assessed physical behaviour and the association with clinical outcomes in implantable cardioverter-defibrillator recipients: a systematic review.
Mr M. Kolk (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Subcutaneous and single-chamber transvenous defibrillators: a nationwide matched control study.
Doctor A. Bodin (Chambray Les Tours, FR)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of subcutaneous implantable cardioverter-defibrillator appropriate and inappropriate shocks
Doctor L. Oliveira (Ponta Delgada, PT)
Abstract Slides Video
Presentation thumbnail
Serratus anterior plane block reduces perioperative sedation use and discharge analgesia in subcutaneous implantable defibrillator implantation
Doctor A. Mistry (Nottingham, GB)
Abstract Slides Video

Access the full session

Session thumbnail
News from ICD therapy

The Event

Event poster

EHRA 2021

23 April - 25 April 2021
You may be interested in
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator
thumbnail
Congress Presentation
When to consider device therapy in HFrEF - discussion
thumbnail
Congress Session
Debate on primary prevention in ICD therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources